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Pasteurella haemolytica Al leukotoxin causes rapid (5 to 15 min) leakage of intracellular K+ and cell swelling
and slower (15 to 60 min), Ca2+-dependent formation of large plasma membrane defects (-100 nm) and
leakage of lactate dehydrogenase from bovine lymphoma cells (BL3 cells) (K. D. Clinkenbeard, D. A. Mosier,
A. L. Timko, and A. W. Confer, Am. J. Vet. Res., in press). Incubation of BL3 cells in medium made
hypertonic by inclusion of 75 mM sucrose blocked leukotoxin-induced cell swelling, formation of large plasma
membrane defects, and leakage of lactate dehydrogenase but did not block leukotoxin-induced leakage of
intracellular K'. Carbohydrates with molecular weights less than that of sucrose, e.g., mannitol, did not block
leukotoxin-induced cell swelling of BL3 cells. Increasing the concentration of mannitol to twice that of sucrose
still resulted in no protective effect. Assuming that leukotoxin acts as a transmembrane molecular sieve, then
the functional transmembrane pore size formed by leukotoxin in BL3 cells is slightly less than the size of
sucrose, i.e., 0.9 nm. Exposure of BL3 cells to leukotoxin for 15 or 45 min followed by the addition of
hypertonic sucrose to the incubation medium reversed leukotoxin-induced cell swelling and prevented further
leakage of lactate dehydrogenase. Leukotoxin-induced leakage of lactate dehydrogenase required both cell
swelling and Ca2+-dependent processes. The Ca2+-dependent steps can occur before or concurrent with cell
swelling.
Pasteurella haemolytica Al, the most common bacterium
isolated from the lungs of cattle with pneumonic pasteurel-
losis (9), produces an exotoxin (leukotoxin) that damages
ruminant leukocytes (1, 2, 15). Leukotoxin, which is com-
posed of 105,000-molecular-weight subunits, has an apparent
molecular weight of >300,000 (8). A DNA fragment coding
for P. haemolytica leukotoxin has been isolated and shares
extensive homology with the gene coding for Escherichia
coli a-hemolysin (11, 16). Exposure of bovine leukocytes to
leukotoxin results in rapid leakage of intracellular K+ (<5
min) and cell swelling (<15 min). A slower Ca2+-dependent
formation of large (100-nm) plasma membrane defects and
leakage of large cytoplasmic components into the media,
e.g., lactate dehydrogenase (LDH), occurs between 15 and
60 min of leukotoxin exposure (K. D. Clinkenbeard, D. A.
Mosier, A. L. Timko, and A. W. Confer, Am. J. Vet. Res.,
in press).
It appears that P. haemolytica leukotoxin injures its target
cells by a mechanism similar to that of several other bacterial
cytolysins, i.e., insertion of the toxin into the plasma mem-
brane with resulting formation of transmembrane pores (6).
These pores allow intracellular K' to leak from the cell, but
larger cytoplasmic components such as proteins are initially
retained within the cell. This toxin-induced molecular siev-
ing results in the intracellular osmotic pressure becoming
greater than that in the medium, and the cells swell. After
swelling, the cells begin to leak larger cytoplasmic compo-
nents (3).
Inclusion of certain carbohydrates in the incubation me-
dium prevents cell swelling caused by pore-forming cytoly-
* Corresponding author.
t Journal article 88-018 from the College of Veterinary Medicine
and the Agricultural Experiment Station, Oklahoma State Univer-
sity.
sins (12). The ability of these agents, termed osmotic stabi-
lizing or protecting agents, to prevent cell swelling is
proportional to their molecular weight and concentration in
the medium. It has been proposed that osmotic stabilizing
agents prevent toxin-induced cell swelling by causing the
medium to be hypertonic compared with the cytoplasm. For
this to occur, the molecular weight of the osmotic stabilizing
agent must be high enough that it cannot pass through the
toxin-formed pores into the cytoplasm, and the concentra-
tion of the agent in the medium must be sufficient to
counterbalance the toxin-induced increase in intracellular
osmotic pressure.
Based on the assumption that pore-forming cytolysins act
as molecular sieves, osmotic stabilizing agents have been
used to estimate the size of toxin-formed transmembrane
pores (4). A series of carbohydrates of differing molecular
weights were used as osmotic stabilizing agents with P.
haemolytica leukotoxin and cultured bovine lymphoma
cells, and the effectiveness of carbohydrates of various
molecular weights in preventing toxin-induced cell swelling
was used to estimate the size of the transmembrane pores
formed by P. haemolytica leukotoxin. Osmotic stabilizing
agents were also used to examine the role of cell swelling in
leukotoxin-induced plasma membrane damage and its rela-
tionship to Ca2+-dependent membrane damage.
MATERIALS AND METHODS
Cultivation techniques. Lyophilized cultures of P. hae-
molytica Al were suspended in distilled water, plated onto
enriched brain heart infusion agar, and grown at 37°C under
5% CO2 for 18 h. Isolated colonies were transferred to 50 ml
of brain heart infusion broth (Difco Laboratories, Detroit,
Mich.) in a 250-ml Erlenmeyer flask and grown at 37°C with
rotatory shaking at 80 oscillations per min for 4 h. These
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cultures were used to inoculate media for the production of
leukotoxin.
Leukotoxin production. Cultures of P. haemolytica pre-
pared as described above were collected by centrifugation
(Sorvall rotor SS34; 12,000 x g for 30 min at 25°C) and
suspended in 10 ml of 3.5% bovine serum albumin in RPMI
1640 medium (Sigma Chemical Co., St. Louis, Mo.) at pH
7.2. The suspended bacteria were used to inoculate 100 to
400 ml of RPMI 1640-3.5% bovine serum albumin in Erlen-
meyer flasks, which were incubated at 37°C for 1 h and then
centrifuged as described above. The supernatant (leuko-
toxin) was filtered through a 0.22-,um filter (Nalgene Filtunit
TYP S CN; Nalge Company, Rochester, N.Y.) and stored at
-70°C. Heat-denatured leukotoxin was prepared by incubat-
ing leukotoxin at 60°C for 10 min.
Cultivation of bovine lymphoma cells. Bovine lymphoma
cells (BL3 cells from G. Theilen, University of California,
Davis) were grown in suspension culture in 50% Leibovitz
L-15-50% Eagle minimal essential medium with 20% fetal
bovine serum to which were added L-glutamine (2 mmol
liter-'), gentamicin (50 mg liter-1) and NaHCO5 (2.2 g
liter-') at 37°C with 5% CO2 (GIBCO Laboratories, Grand
Island, N.Y.). Cells used for leukotoxin assays were split 1:1
in the above media and grown for 1 day before use. The cell
concentration was determined by manual cell counts (Uno-
pette System 5856; Becton-Dickinson Vacutainer Systems,
Rutherford, N.J.). The cells were harvested by centrifuga-
tion (IEC Centrac rotor 216; 700 x g for 10 min at 25°C), the
supernatant was discarded, and the pellet was suspended at
the desired cell concentration for use.
Characterization of leukotoxin. Three leukotoxin prepara-
tions were used in these experiments. The leukotoxin prep-
arations had half-lives of inactivation at 60°C of 1.3 min for
K+ leakage and 1.5 min for LDH leakage from BL3 cells.
Leukotoxin preparations caused leakage of K+ and LDH
from isolated bovine neutrophils and lymphocytes and BL3
cells but not from bovine erythrocytes or cultured Madin-
Darby bovine kidney cells. Antibodies to purified leukotoxin
(14) neutralized .90% of the leukotoxin activity of these
preparations as assessed by LDH leakage from BL3 cells.
Potassium release assay. BL3 cells (5.6 x 107 cells per ml)
in 0.5 ml of 10 mM Tris-140 mM NaCl (pH 7.3) with or
without 75 mM sucrose were incubated at 25°C for 20 min
with heat-denatured leukotoxin or native leukotoxin (240
TU). The cells were removed by centrifugation (Triac mi-
crohemocrit rotor; 11,700 x g for 3 min; Clay-Adams,
Rutherford, N.J.) in microhematocrit tubes, and the K+ in
the supernatant was measured by using an ion-specific
electrode (ACA11-60; Du Pont Co., Wilmington, Del.).
PCV. Assay mixtures were incubated with oscillatory
shaking (50 oscillations per min) for the time periods indi-
cated. Samples of the assay mixtures were transferred to
microhematocrit tubes and centrifuged as described above.
The packed cell volume (PCV) was derived by dividing the
height of the column of packed cells by the height of the
column of packed cells plus the fluid column multiplied by
100 and expressed as the percentage of the total volume.
LDH activity release assay. Assay mixtures were incubated
with oscillatory shaking (50 oscillations per min) for the time
periods indicated. Samples were then centrifuged (Surespin
centrifuge; Helena Laboratories, Beaumont, Tex.; 5,800 x g
for 2 min), and LDH activity in the supernatant was mea-
sured spectrophotometrically (LDL50; Sigma) (Gilford Sys-
tem 5 Clinical Chemistry Analyzer; Gilford Instrument Lab-
oratories, Inc., Oberlin, Ohio) at 30°C.
TU. One toxic unit (TU) is the amount of leukotoxin that
TABLE 1. Osmotic protection of BL3 cells from leukotoxin-
induced cell swelling and LDH leakagea
LDH
Carbohydrate Molecular Change in leakagec
(mM) weight PCVb (%) (mU per
assay)
None 30.7 ± 0.6 325.5 ± 45.8
Glycerol (75) 92.1 31.3 ± 1.5 315.3 ± 68.2
Mannitol (75) 182.2 31.3 ± 0.6 175.7 ± 12.8
Sedoheptulose (75) 210.2 30.0 ± 1.0 171.9 ± 8.4
N-Acetylmannosamine (75) 239.2 24.3 ± 1.2 51.4 ± 21.7
Sucrose (75) 342.3 5.3 ± 0.6 65.8 ± 12.8
Inulin (25) =5,000 -2.7 ± 0.6 46.7 ± 9.7
a BL3 cells (108) in 0.5 ml of 10 mM Tris-140 mM NaCI (pH 7.3) containing
1 mM CaCl2 and carbohydrate as indicated were incubated with native or
heat-denatured leukotoxin (100 TU) at 37°C.
b LKT-induced PCV after 30 min of incubation minus control PCV (mean +
standard deviation for three samples). The initial PCV was 19%o.
I LKT-induced LDH leakage (expressed as mU per 10-Jl assay out of a
500-p,u total assay volume) after 120 min of incubation minus LDH leakage
from control cells incubated with heat-denatured LKT in the same incubation
medium (mean ± standard deviation, assay volume for three samples). Triton
X-100 released 617 mU per assay.
caused -50% leakage of the total LDH activity from 5 x 105
BL3 cells in 0.25 ml of RPMI after 120 min of incubation at
37°C. Leukotoxin preparations typically contained 8,000
TU/ml.
Scanning electron microscopy. BL3 cells (5 x 107) in 0.5 ml
ofRPMI 1640 medium with and without 75 mM sucrose were
incubated with or without leukotoxin (100 TU) at 37°C for 30
min. After incubation, cells were fixed in 2.5% glutaralde-
hyde, washed in cacodylate buffer, attached to 1% polyly-
sine-coated cover slips, and dehydrated by sequential
washes in increasing strengths of ethanol (50 to 100%).
Cover slips were critical point dried, mounted on aluminum
stubs, coated with gold-palladium, and examined with a
scanning electron microscope (JSM 35-U; JEOL Ltd., To-
kyo, Japan).
Reproducibility of experimental data. The data reported
are means for three or more samples or are representative
data for experiments that were conducted two or more times
with essentially identical results.
RESULTS
Exposure of bovine lymphoma cells (BL3 cells) to P.
haemolytica leukotoxin resulted in rapid cell swelling as
measured by increased PCV (Table 1). The protective effects
of osmotic stabilizing agents on leukotoxin-induced cell
swelling were tested by using carbohydrates of molecular
weights ranging between 92.1 and 5,000. Leukotoxin-in-
duced cell swelling was decreased for media containing
carbohydrates with molecular weights of >239.2 (Table 1).
Although inclusion of 75 mM sucrose blocked leukotoxin-
induced cell swelling, it did not block leukotoxin-induced
leakage of intracellular K+ (Table 2). In addition to K+
leakage and cell swelling, leukotoxin exposure of BL3 cells
caused leakage of the cytoplasmic enzyme LDH into the
incubation medium (Table 1). Inclusion of osmotic stabiliz-
ing agents with molecular weights of .182.2 reduced the
leukotoxin-induced leakage of LDH activity.
The concentration dependence of sucrose protection of
BL3 cells from leukotoxin-induced cell swelling and LDH
leakage is shown in Fig. 1. Increasing sucrose concentra-
tions caused a steady decrease in cell swelling and LDH
leakage. Maximal protective effects were reached at sucrose
VOL. 57, 1989 421
422 CLINKENBEARD ET AL.
TABLE 2. Sucrose prevents leukotoxin (LKT)-induced cell
swelling but not K+ leakage from BL3 cells
Incubation conditions K+ leakage PCV (%)b(p.Eq)'
No sucrose
Heat-denatured LKT 2.88 ± 0.00 10.8 ± 0.7
Native LKT 20.43 ± 0.27 19.7 ± 0.5
Sucrose (75 mM)
Heat-denatured LKT 2.97 + 0.03 9.3 ± 0.5
Native LKT 20.13 + 0.36 10.0 ± 0.6
a Mean ± standard deviation for three samples; 21.00 p.Eq of K+ was
released by 0.1% Triton X-100.
b Mean ± standard deviation for six samples.
concentrations of 54 mM for cell swelling and 38 mM for
LDH leakage. In contrast, increasing the concentration of
mannitol in the incubation medium did not protect BL3 cells
from leukotoxin-induced cell swelling or LDH leakage (Fig.
2), even when the concentration of mannitol was twice that
of sucrose. Increasing sucrose or mannitol concentrations
did cause control cells to shrink during the 30-min incubation
period (maximal decrease in PCV was 2%), but mannitol or
sucrose concentrations of 150 or 75 mM, respectively, had
no effect on background or total cellular LDH activity.
The ability of sucrose to protect BL3 cells preexposed to
leukotoxin for 15 or 45 min was examined to determine
whether the osmotic protection was lost under these condi-
tions. The addition of sucrose to the incubation medium at a
final concentration of 75 mM after either 15 or 45 min of
leukotoxin exposure reversed the leukotoxin-induced cell
swelling and stopped further leukotoxin-induced leakage of
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FIG. 1. Osmotic protection by sucrose of BL3 cells exposed to
leukotoxin. BL3 cells (2.8 x 107) suspended in 0.25 ml of RPMI
containing 0 to 75 mM sucrose were exposed'to leukotoxin (40 TU).
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FIG. 2. Lack of osmotic protection by mannitol of BL3 cells
exposed to leukotoxin. Experiment conditions were as described in
the legend to Fig. 1, except that cells were suspended in RPMI
containing 0 to 150 mM mannitol and exposed to leukotoxin (100
TU). Symbols: O, PCV; U, LDH activity.
min of leukotoxin exposure when ==50% of the cellular LDH
had been leaked.
Exposure of BL3 cells to leukotoxin in medium containing
Ca2" resulted in the formation of large plasma membrane
defects as observed by scanning electron microscopy (Fig.
4). After 30 min of exposure of BL3 cells to leukotoxin, the
cells were larger (Fig. 4c) than BL3 cells not exposed to
leukotoxin (Fig. 4a), and many had large plasma membrane
defects (Fig. 4c). In contrast, BL3 cells that were exposed to
leukotoxin for 30 min in incubation medium containing 75
mM sucrose developed a finely porous appearance to the
plasma membrane and some large mnembrane blebs (Fig. 4d),
but these cells did not become enlarged or develop large
plasma membrane defects. Observation by electron micros-
copy of cell swelling and formation of large plasma mem-
brane defects caused by exposure to leukotoxin also corre-
lated with leakage of LDH activity by these cells. Cells not
exposed to leukotoxin (Fig. 4a and b) and those exposed tG
leukotoxin in the presence of 75 mM sucrose (Fig. 4d) leaked
-10% of their total cellular LDH activity, whereas the BL3
cells exposed to leukotoxin in the absence of added sucrose
(Fig. 4c) leaked -905% of their total cellular LDH activity.
The relationship between leukotoxin-induced cell swelling
and Ca2"-dependent LDH leakage was examined by expos-
ing BL3 cells to leukotoxin in sucrose-containing medium to
prevent cell swelling and then suspending the exposed cells
in medium lacking sucrose to allow cell swelling. Initially,
BL3 cells were incubated with leukotoxin in medium con-
taining 75 mM sucrose with either 1 mM Ca2+ or
5 mM EGTA [ethylene glycol-bis(,B-aminoethyl ether)-
N,N,N',N'-tetraacetic acid] for 30 min, after which the cells
were suspended in medium lacking sucrose but containing
either 1 mM Ca2+ or 5 mM EGTA. Initial incubation in
medium containing sucrose and Ca2+ resulted in rapid
leakage of LDH from the cells after suspension in medium
lacking sucrose, even when the suspension medium did not
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FIG. 3. Osmotic protection of BL3 cells preexposed to leuko-
toxin. BL3 cells (7.5 x 107) in 0.75 ml of 10 Tris-140 NaCl (pH
7.3)-i mM CaC12 were incubated with leukotoxin (80 TU), and the
PCV (A) and LDH release (B) were measured. At either 15 min (A,
A) or 45 min (L, *) 50% sucrose was added to yield a final
concentration of 75 mM sucrose, or no sucrose was added (O, *).
Control cells exposed to heat-denatured leukotoxin exhibited no
change during the 90-min incubation period in PCV (PCV, 6%) or
LDH leakage (3.2 U). Triton X-100 released 26.6 U of LDH.
contain Ca2+ (Fig. 5a). Cell swelling could not be measured
in these cells because they aggregated immediately upon
suspension. In a parallel experiment (Fig. Sb), in which the
initial incubation medium contained sucrose but no Ca2+
suspension in medium lacking sucrose resulted in rapid cell
swelling (PCV increased from 16 to 24%); when Ca2+ was
included in the suspension medium, there was a slower but
complete leakage of LDH (99%), but when Ca2+ was omit-
ted only 40% of the cellular LDH was leaked.
FIG. 4. Sucrose prevents cell swelling and formation of large
plasma membrane defects in BL3 cells exposed to leukotoxin.
Shown are scanning electron micrographs of unexposed BL3 cells in
RPMI alone (a) or RPMI with 75 mM sucrose (b) and BL3 cells
exposed to leukotoxin in RPMI alone (c) or RPMI with 75 mM
sucrose (d) as described in Materials and Methods.
DISCUSSION
P. haemolytica leukotoxin causes rapid leakage of intra-
cellular K+ and subsequent colloid osmotic swelling of BL3
cells. We have shown that incubation medium made hyper-
tonic by the addition of carbohydrate molecules with molec-
ular weights of .342.3 prevented leukotoxin-induced cell
swelling but not K+ leakage from BL3 cells. We suggest,
based on these findings, that leukotoxin initially forms
plasma membrane pores of approximately 0.9 nm in func-
tional diameter. This pore diameter is smaller than that
estimated for pores formed by E. coli a-hemolysin (2 to 3
nm) or Staphylococcus aureus a-toxin (2 to 3 nm) with this
method (5, 6). Sucrose has been shown to osmotically
protect Vero cells from damage by Clostridium perfringens
enterotoxin (13), suggesting that the functional pore size
caused by this enterotoxin is similar to that of the pore
formed by leukotoxin.
After leukotoxin-induced K+ leakage and cell swelling,
leukotoxin-exposed BL3 cells form large plasma membrane
defects and leak LDH. Inclusion of 75 mM sucrose in the
incubation medium prevented formation of large plasma
membrane defects and leakage of LDH. It appears that cell
swelling is required for leukotoxin-induced formation of
large plasma membrane defects and LDH leakage. This
conclusion is further supported by the reversal of cell
swelling and cessation of LDH leakage caused by the
addition of hypertonic concentrations of sucrose to cells
undergoing leukotoxin-induced changes.
The effects of sucrose on cell swelling and LDH leakage
had different concentration dependences. Sucrose at con-
centrations of .38 mM blocked LDH leakage, but sucrose at
concentrations c54 mM only partially prevented cell swell-
ing. This may indicate that a certain threshold of cell
swelling is required before large plasma membrane defects
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FIG. 5. Ca2+-dependent steps required for leukotoxin-induced
cytolysis can precede or follow cell swelling. BL3 cells (1.5 x 108)
were exposed to native (D, O) or heat-denatured (A, A) leukotoxin
(900 U) in 0.75 ml of 10 mM Tris-140 mM NaCl (pH 7.3)-75 mM
sucrose containing either 1 mM CaC12 (A) or 5 mM EGTA (B) for 30
min at 37°C. The cells were then collected by centrifugation (5,800 x
g for 2 min) and washed with 10 mM Tris-140 mM NaCl-75 mM
sucrose-5 mM EGTA. The washed cells were suspended in 10 mM
Tris-140 mM NaCl lacking sucrose but, containing either 1 mM
CaCl2 (D, A) or 5 mM EGTA (O, A). Triton X-100 (0.1%, vol/vol)
released 68 U of LDH.
develop and LDH leakage occurs. The involvement of a cell
swelling threshold is supported by observations of the action
of Actinobacillus actinomycetemcomitans leukotoxin on hu-
man monocytes; the leakage of large cytoplasmic compo-
nents occurs by explosive ejection of the cytoplasm rather
than a gradual, continuous leakage of cytoplasmic compo-
nents (17). The combination of weakened areas in the plasma
membrane and increased internal hydrostatic pressure
caused by cell swelling may result in sudden lysis of the
plasma membrane and ejection of the cytoplasm when this
threshold is exceeded.
It was previously shown that Ca2" is required for certain
types of leukotoxin-induced damage to BL3 cells, e.g.,
morphologic changes, altered vital dye uptake, decreased
[3H]thymidine incorporation into DNA, and leakage ofLDH
and 51Cr (D. G. Gerbig, J. S. Foster, R. D. Walker, D. A.
Bemis, and R. N. Moore. Abstr. Int. Symp. Virulent Mech-
anisms of Veterinary Bacterial Pathogens 1987, Iowa State
University, Ames; Clinkenbeard et al., in press). All of these
Ca2"-dependent changes may be the direct manifestations of
the formation of large plasma membrane defects that require
both Ca2" and cell swelling. Other bacterial cytolysins also
require Ca2" for their action (7, 10); however, the function of
Ca2" in the cytolytic activity of these toxins has not been
well defined. Calcium may be required for toxin-induced
phospholipase metabolism of plasma membrane phospholip-
ids, resulting in the formation of the large plasma membrane
defects, or the toxin-induced influx of Ca2" may cause the
disruption of the cytoskeleton, resulting in the loss of plasma
membrane strength. Although both Ca2"-dependent steps
and cell swelling are required for P. haemolytica leukotoxin-
induced cytolysis of BL3 cells, the temporal relationship
between these steps does not appear to be important; i.e.,
incubation with Ca2" before or concurrent with cell swelling
resulted in LDH leakage.
The action of P. haemolytica leukotoxin on BL3 cells
results in a sequence of cell-damaging events, beginning with
leakage of intracellular K+ and ending with the formation of
large plasma membrane defects and loss of the cytoplasm.
Cell swelling is the second event in this process, and when it
is prevented, subsequent cell-damaging events are prevented
from developing.
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